(Q36654072)

15 August 2017

1 reference

title

Tumor antigen-based immunotherapy and immunoprevention of cancer (English)

1 reference

15 August 2017

1 reference

Sean O Ryan

1

1 reference

15 August 2017

Kira R Gantt

series ordinal

2

1 reference

15 August 2017

Olivera J Finn

series ordinal

3

1 reference

15 August 2017

language of work or name

1 reference

13 November 2006

1 reference

International Archives of Allergy and Immunology

15 August 2017

published in

1 reference

15 August 2017

volume

142

1 reference

15 August 2017

issue

3

1 reference

15 August 2017

page(s)

179-189

1 reference

Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden.

15 August 2017

cites work

1 reference

Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy

21 January 2018

1 reference

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

21 January 2018

1 reference

Paradoxical roles of the immune system during cancer development

21 January 2018

1 reference

Targeting cyclooxygenase-2 in human neoplasia: rationale and promise

21 January 2018

1 reference

Polymorphic epithelial mucin (MUC-1)-containing circulating immune complexes in carcinoma patients

21 January 2018

1 reference

Induction of impaired antitumor immunity by fusion of MHC class II-deficient dendritic cells with tumor cells.

21 January 2018

1 reference

Inhibition of breast and ovarian tumor growth through multiple signaling pathways by using retrovirus-mediated small interfering RNA against Her-2/neu gene expression

21 January 2018

1 reference

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

21 January 2018

1 reference

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

21 January 2018

1 reference

HSP110-HER2/neu Chaperone Complex Vaccine Induces Protective Immunity Against Spontaneous Mammary Tumors in HER-2/neu Transgenic Mice

21 January 2018

1 reference

Early role of CD4+ Th1 cells and antibodies in HER-2 adenovirus vaccine protection against autochthonous mammary carcinomas.

21 January 2018

1 reference

Effect of dose on immune response in patients vaccinated with an her-2/neu intracellular domain protein--based vaccine

21 January 2018

1 reference

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

21 January 2018

1 reference

Specific carcinoembryonic antigens of the human digestive system

21 January 2018

1 reference

Mouse models expressing human carcinoembryonic antigen (CEA) as a transgene: evaluation of CEA-based cancer vaccines

21 January 2018

1 reference

Cancer immunotherapy: moving beyond current vaccines

21 January 2018

1 reference

Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma

21 January 2018

1 reference

Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going?

21 January 2018

1 reference

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

21 January 2018

1 reference

Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000097020

1 reference

15 August 2017

1 reference